{
  "id": "SCR-LIP-000671",
  "statement": "The proposed rationale for gestrinone in lipedema rests on hypothesised aromatase inhibition and estrogen-receptor blockade, supported only by theoretical and in vitro data.",
  "claim_type": "clinical_association",
  "context": {
    "population": "women with lipedema (hypothetical/proposed)",
    "condition": "lipedema",
    "exposure": "gestrinone (aromatase inhibitor, ER blocker)",
    "comparator": "—",
    "outcome": "mechanistic rationale; in vitro cell viability only",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "very_low",
  "evidence": [
    {
      "ref": "DOI:10.3390/ph17091248",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2024,
      "amato_authored": false,
      "note": "The article is a narrative/mechanistic review that proposes gestrinone use in lipedema as a new application, offering a speculative aromatase-inhibition rationale and only in vitro cell data; it provides no clinical efficacy evidence in lip",
      "title": "Effects, Doses, and Applicability of Gestrinone in Estrogen-Dependent Conditions and Post-Menopausal Women",
      "authors": "Renke et al.",
      "journal": "Pharmaceuticals",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article is a review that proposes a mechanistic rationale for gestrinone in lipedema (aromatase overexpression, anti-aromatase and anti-estrogenic effects, anti-adipogenic cascade) but provides only in vitro MTT cell-viability data (MDA",
        "date": "2026-06-10"
      },
      "quote": "Mecanismo proposto para o lipedema: na doença há superexpressão de aromatase no tecido adiposo, aumentando a conversão de androgênios em estrogênios e alimentando a fisiopatologia; a gestrinona inibiria a aromatase e bloquearia receptores estrogênicos.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "Review proposes gestrinone for lipedema based on aromatase overexpression in lipedema adipose tissue, hypothesising aromatase inhibition and estrogen-receptor blockade; presents only in vitro cell-viability data (MTT, MDA-MB-231 and Huh7), no clinical trial.",
      "from_claims": [
        "SCR-LIP-000329"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000329"
  ],
  "questions_consolidated": [
    "SQ-LIP-000016"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00036",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000016"
    }
  ],
  "statement_pt": "A justificativa proposta para a gestrinona no lipedema baseia-se em hipotética inibição da aromatase e bloqueio dos receptores de estrogênio, sustentada apenas por dados teóricos e in vitro.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000016",
      "role": "context",
      "question": "Is gestrinone an effective treatment for lipedema?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000016.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000671.html"
}